Precision Cardiac Care

Where every second is a
clinical decision

Heart Bio Line engineers rapid-response loading-dose therapies for acute cardiovascular intervention — built for the critical moments where hesitation is not an option.

Explore Therapies Our Science →
Cardiac Monitor · ICU-7
Live
72 bpm Heart Rate
98 % SpO₂
120 mmHg Systolic BP
HBL-CARDIO · v4.2.1 Protocol Active
98.7%
Bioavailability Rate
<90s
Onset to Therapeutic Effect
40+
Hospital Partnerships
ISO 9001
Certified Manufacturing
24/7
Clinical Support Line
Our Mission

Precision-engineered for the critical moment

Heart Bio Line was founded on a singular conviction: that acute cardiovascular care demands pharmaceutical solutions held to the highest possible standard of speed, accuracy, and reliability.

"In the first minutes of a cardiac event, every therapeutic decision carries the weight of irreversibility. We build for that moment."
Scientific Rigor
Every formulation undergoes multi-stage clinical validation, ensuring therapeutic consistency across patient populations and clinical contexts.
Rapid-Response Design
Our loading-dose architecture is engineered for sub-90-second onset, closing the gap between administration and therapeutic effect.
Uncompromising Quality
ISO 9001-certified facilities, GMP-compliant processes, and real-time batch analytics underpin every vial that leaves our production line.
Therapeutic Portfolio

Formulations built for acute cardiac response

Our portfolio spans the critical spectrum of immediate cardiac intervention — from anticoagulation to antiarrhythmic loading doses, each precision-calibrated for emergency deployment.

Flagship
HBL-001
CardioLoad Pro
Rapid-Dose Anticoagulant
Precision-engineered heparin loading formulation optimised for STEMI protocols, delivering predictable anticoagulation with minimal inter-patient variability.
Onset< 60 sec IV
RouteIV Bolus / Infusion
ProtocolACC/AHA Aligned
HBL-002
AmioPulse
Antiarrhythmic Loading
Amiodarone loading solution engineered for ventricular fibrillation and haemodynamically unstable VT — stable across a wide temperature range for emergency cart storage.
Onset~90 sec IV
RouteIV Bolus
Storage2–30°C
HBL-003
ThromboClear
Fibrinolytic Loading Agent
Tissue plasminogen activator formulation designed for acute ischaemic stroke and pulmonary embolism — pre-calculated weight-based dosing reduces administration error in high-pressure environments.
Onset~2 min
RouteIV Infusion
Window0–4.5 hr
HBL-004
VasoPrime
Vasopressor Loading
Norepinephrine and vasopressin combination loading solution for cardiogenic shock — formulated in a stable, light-protected carrier for rapid assembly and deployment.
Onset1–3 min
RouteCentral IV
IndicationCardiogenic Shock
HBL-005
BetaShield
Beta-Blocker Loading
Metoprolol tartrate loading formulation for rate control in atrial fibrillation with rapid ventricular response — optimised pharmacokinetics reduce time to rate control by up to 40%.
Onset1–2 min
RouteIV Bolus
TargetAF Rate Control
HBL-006
PlatePause
Antiplatelet Loading
High-dose aspirin and P2Y12 inhibitor dual loading combination for NSTEMI and STEMI pre-catheterisation — formulated for rapid absorption with reduced GI exposure.
Onset~15 min oral
RouteOral / NG
ProtocolESC 2023 Aligned
Our Approach

The science of immediacy

We apply a rigorous, multi-layered development framework — from molecular optimisation to real-world clinical deployment — ensuring that every therapy performs exactly when it must.

Research Focus

Loading-dose pharmacology at the intersection of bioavailability optimisation, formulation stability, and clinical safety margin engineering — built around the specific physiology of the acutely compromised heart.

01
Molecular Optimisation
Active pharmaceutical ingredient profiling and salt-form selection for maximum aqueous solubility and IV compatibility under physiological conditions.
02
Formulation Engineering
Carrier system design that maximises bioavailability while ensuring chemical stability across the cold chain and emergency storage environments.
03
Preclinical PK/PD Modelling
Pharmacokinetic and pharmacodynamic simulation across physiological extremes — accounting for haemodynamic compromise, renal impairment, and polypharmacy interactions.
04
Clinical Validation
Phase II/III trials in acute cardiac care settings, with endpoint focus on time-to-therapeutic-effect, adverse event rates, and clinician usability under emergency conditions.
05
Post-Market Surveillance
Continuous real-world performance monitoring with pharmacovigilance integration — feeding data back into the next iteration of formulation refinement.
Why Heart Bio Line

Built for the front line of cardiac care

Protocol-Aligned Formulations
Every product is designed to integrate seamlessly with ACC, AHA, and ESC emergency cardiac care guidelines — reducing cognitive load at the point of use.
Sub-90-Second Onset
Our loading-dose architecture consistently achieves therapeutic plasma levels within 90 seconds of IV administration, validated across patient populations.
GMP-Certified Manufacturing
ISO 9001 and GMP-compliant production with full batch traceability, validated cleaning processes, and continuous environmental monitoring.
Safety-First Engineering
Wide therapeutic index margins, built-in compatibility with standard IV lines, and colour-coded packaging that minimises preparation error in high-pressure environments.
Our Journey

A foundation of continuous innovation

Founded
Heart Bio Line Established
Founded by a team of clinical pharmacologists and cardiologists with a mandate to close the gap between emergency cardiac need and pharmaceutical response.
Year 2
CardioLoad Pro Launched
First product — CardioLoad Pro — receives regulatory approval and is adopted by 12 tertiary cardiac centres in Phase 1 roll-out.
Year 3
ISO 9001 Certification
Manufacturing facility achieves ISO 9001 and GMP certification, establishing the quality infrastructure for scaled production.
Year 4
Portfolio Expansion to 6 Therapies
AmioPulse, ThromboClear, and VasoPrime approved and commercially deployed, completing the acute intervention spectrum.
Present
40+ Hospital Network
Heart Bio Line therapies are now standard-of-care in over 40 hospital systems. Next-generation formulations are in Phase II development.
Clinical Perspectives

Trusted by the clinicians who matter most

"

CardioLoad Pro has changed how our STEMI team operates. The predictability of the anticoagulation response has reduced our door-to-balloon time variability considerably — that translates directly to outcomes.

RS
Dr. R. Sharma
Interventional Cardiologist · Cardiac Centre, Mumbai
"

In the resus bay, clarity is everything. The colour-coded packaging and pre-calculated dosing of AmioPulse means my team can act in seconds, not minutes. That is not a small thing when you are dealing with VF.

MA
Dr. M. Al-Rashid
Emergency Medicine Consultant · Regional Trauma Centre
"

What differentiates Heart Bio Line is the stability data. ThromboClear performs consistently whether it has been at 4°C or 28°C — for a hospital pharmacy managing cold chain across a large campus, that matters enormously.

LK
L. Krishnamurthy
Chief Pharmacist · University Medical Centre
Get in Touch

Partner with Heart Bio Line

Whether you are a hospital formulary committee, an emergency department lead, or a procurement partner — we are ready to support your critical care needs.

Request a Clinical Dossier View Product Portfolio
Medical Affairs
medaffairs@heartbioline.com
24/7 Clinical Support
+91 97876 66687
Pharmacovigilance
safety@heartbioline.com
Corporate Headquarters

Visit Our Office

207, Srinivasa Perumal Complex, II Floor,
Dr Rajendra Prasad Rd,
Coimbatore, Tamil Nadu 641012

Get Directions